Bracing NK Cell Based Therapy to Relegate Pulmonary Inflammation in COVID-19

Investigators discuss the possible use of natural killer (NK) cells cells as a therapeutic agent in view of preventing immunological harms of SARS-CoV-2 and the current challenges in advocating NK cell therapy for the same.